Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.

about

Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.

Item

http://www.wikidata.org/entity/Q48268832

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Intravitreal triamcinolone ace ...... dose intravitreal bevacizumab.

@en

Intravitreal triamcinolone ace ...... dose intravitreal bevacizumab.

@nl

type

Item

label

Intravitreal triamcinolone ace ...... dose intravitreal bevacizumab.

@en

Intravitreal triamcinolone ace ...... dose intravitreal bevacizumab.

@nl

prefLabel

Intravitreal triamcinolone ace ...... dose intravitreal bevacizumab.

@en

Intravitreal triamcinolone ace ...... dose intravitreal bevacizumab.

@nl

P1476

Intravitreal triamcinolone ace ...... -dose intravitreal bevacizumab

@en

P2093

Sonal S Chaugule

http://www.w3.org/2001/XMLSchema#string

P2860

Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy

The efficacy of focal laser therapy in radiation-induced macular edema.

Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy.

Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.

Alterations in the intraocular cytokine milieu after intravitreal bevacizumab.

Regulators of vascular permeability: potential sites for intervention in the treatment of macular edema.

Sector laser photocoagulation for the prevention of macular edema after plaque radiotherapy for uveal melanoma: a pilot study.

Fluorescein angiographic features, natural course and treatment of radiation retinopathy.

Clinicopathological characteristics of vascular endothelial growth factor expression in uveal melanoma: A meta-analysis.

Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity.

P304

1694-1698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJOPHTHALMOL-2017-310315

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Paul T. Finger

Richard I Kaplan

P577

2017-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28416492

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

P932

5754875

http://www.w3.org/2001/XMLSchema#string